Fig. S1: Calcium flux studies.
Intracellular Ca
2+ levels were analyzed in SH-SY5Y cells preloaded with the Ca 2+ dye indicator Fluo-4AM. In a typical experiment, the amyloid protein (A1-42 in this case) was added at a concentration of 220 nM (blue curve). A control experiment with vehicle alone (either H 2 0 or 1% NH 4 OH) was conducted in parallel (red curve). Signals were expressed as fluorescence after treatment (F t ) divided by the fluorescence before treatment (F 0 ) and multiplied by 100. The results were then averaged and the fluorescence of control is subtracted of each value. Data are expressed as mean ± S.E.M. (n = 100). Determinations of methyl--cyclodextrin concentration in the incubation medium (1 mM) and in the washing medium after the 1 st (R1) and 2 nd (R2) washes. After the 1 st rinse the concentration of residual methyl--cyclodextrin is decreased by 83 times (12 vs 1000 M) to reach undetectable levels after the 2 nd rinse. From these data, it can be deduced that after the last (6 th ) wash preceding the addition of the amyloid proteins, residual methyl--cyclodextrin in the incubation medium is as low as 3.10 -15 M. In fact, only three washes are needed to reach a concentration of 1.74 nM, a value that is far below the concentration of amyloid proteins used in the amyloid pore-forming assay (220 nM). Data are expressed as mean ± S.E.M. (n = 2). Cell surface detection of GM1 ganglioside was assessed by immunofluorescence staining of control or PPMP-treated SH-SY5Y cells (scale bar = 100 µm). These data showed that PPMP treatment (10 M, 48hr) induced a dramatic decrease of the cell surface expression of GM1. The anti-ganglioside GM1 antibody was revealed with goat anti-rabbit Alexa Fluor 488. A ternary monolayer consisting of GM1/cholesterol/POPC (1/1/1, mol/mol/mol) was prepared at the air-water interface (initial surface pressure of 20 mN.m -1 ) as described in 1 . This reconstituted membrane forms a meniscus with a fixed area. After solvent evaporation, A1-42, A1-16 or an equimolar mixture of both (80 nmol each) was added in the aqueous subphase underneath the monolayer. The interaction with the GM1 raft-like membrane was followed kinetically (panel A) or after 30 minutes of incubation (panel B) by measuring the surface pressure increase induced by the proteins (). In both panels the arithmetic sum of the surface pressure increase induced by each individual protein is shown in red (theoretical value). Note that in every case the surface pressure increase induced by the A1-42/A1-16 mixture matches the theoretical values calculated by the addition of the induced by each single protein. These data show that A1-42 and the GBD peptide do not interact together in solution since both bind to GM1, which, in this experiment, is present in large excess in the monolayer compared to the protein concentration. On the surface of neural cells, the amounts of GM1 are much lower so that A1-42 and the GBD peptide would compete for GM1 binding. Data are expressed as mean ± S.E.M. (n = 3). GBD, ganglioside-binding domain; POPC, palmytoyl-oleoylphosphatidylcholine. . These data showed that A1-16 binds to a cell component (GM1) and not to the fulllength A1-42 protein. By saturating the GM1 sites on the cell surface before the addition of A1-42, the GBD peptide prevents the specific attachment A1-42 on the cell surface and thus blocks amyloid pore formation. The chimeric -syn/A peptide has been described previously 1 . It recognizes all human brain gangliosides including GM1, GM3, GM4, GD1a, GD1b, and GT1b and thus blocks the initial interaction of amyloid proteins with cell surface gangliosides. The activity of bexarotene against amyloid pores has been described 4 . Both cholesterol and bexarotene share a common amphipathic structure with a large polycyclic apolar domain and a small polar head. 4 and -synuclein (region 67-79 as described in the figure). Bexarotene has a higher affinity for amyloid proteins than cholesterol, which explains why it prevents amyloid pore formation when present in competition at equimolar concentrations 5 . E, energy of interaction of the cholesterol/-synuclein and bexarotene/-synuclein complexes.
